Regeneron Pharmaceuticals is a biopharmaceutical company that discovers, develops, and commercializes pharmaceutical products for the treatment of serious medical conditions. The Company has therapeutic candidates in clinical trials for the potential treatment of cancer, eye diseases, and inflammatory diseases, and has preclinical programs in other diseases and disorders. The company’s product portfolio includes EYLEA, an aflibercept injection; ARCALYST, a rilonacept Injection for subcutaneous use; ZALTRAP for metastatic colorectal cancer; trap fusion proteins; and fully human monoclonal antibodies. On March 26, 2012, it was announced that Sanofi and Regeneron are in development with a new cholesterol drug which will help reduce cholesterol up to 72%. Regeneron Pharmaceuticals was founded in 1988 and is currently headquartered in New York, USA.

PerSeptive Biosystems develops instrumentation systems and consumable products for the purification, analysis, and synthesis of biomolecules. It develops and markets instrument-based systems, reagents, software, and contract services to the life science industry and research community. Customers of PerSeptive Biosystems use these tools to analyze nucleic acids (DNA and RNA) and proteins in order to make scientific discoveries, develop new pharmaceuticals, and conduct standardized testing. Founded in 1989, PerSeptive Biosystems is based in Framingham, Massachusetts. Currently, it operates as a subsidiary of Life Technologies Corporation.

Nanjing Shannuo Biotechnology Co., Ltd., established on 2012-11-21, Business scope includes bioengineering research and development,technical consulting;Instrumentation and consumables sales;Self-operated and agent import and export business of various commodities and technologies(Except for commodities and technologies that the state restricts enterprises to operate or prohibits import and export).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Merck Millipore was the brand used for Merck's global life science business until 2015 when the company re-branded. It was originally formed when Merck acquired the Millipore Corporation in 2010. Merck is a supplier to the life science industry. The Millipore Corporation was founded in 1954, and listed among the S&P 500 since the early 1990s, as an international biosciences company, known widely for its micrometer pore-size filters and tests. In 2015, Merck acquired Sigma-Aldrich and merged it with Merck Millipore. In the United States and Canada, the life science business is now known as MilliporeSigma.

Sanofi Genzyme is the specialty care global business unit of Sanofi, focused on rare diseases, multiple sclerosis, immunology, and oncology. They help people with debilitating and complex conditions that are often difficult to diagnose and treat. They are dedicated to discovering and advancing new therapies, providing hope to patients and their families around the world. Genzyme became part of Sanofi in 2011. While continuing to focus on rare diseases, they also established ourselves as a leader in the field of multiple sclerosis. In 2016, their focus expanded to include Sanofi’s programs in oncology and immunology. Their approach is shaped by a long history of developing highly specialized treatments and forging close relationships with physician and patient communities. Founded as Genzyme in Boston in 1981, they rapidly grew to become one of the world’s leading biotechnology companies, recognized for their pioneering development of treatments for rare genetic disorders and their innovative contributions to medical science and biomanufacturing.

Suzhou Sepu Instrument Co., Ltd., established on 2011-04-25, The business scope includes the research and development of biochemical drug separation and purification detection instruments,Production,Sales and provision of related technical services,Certification Services;Self-operated and agent import and export business of various commodities and technologies. (Items subject to approval by law,Business activities can only be carried out after approval by relevant departments) General project:Manufacturing of experimental analysis instruments;Manufacturing of electronic measuring instruments;Sales of electronic measuring instruments;Special Equipment Repair;Machinery and Equipment Leasing;Medical equipment rental;rental service(Does not include publication rental);software development;software sales;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Founded in Suzhou Industrial Park since 2009, Lisure Science (Suzhou) Co., Ltd is a national hi-tech enterprise. Currently, Lisure has set up with one 20,000㎡production facility (Shengpu) and one 3,000㎡application center (Biobay) . Lisure Science is a professional provider of technology and products in biopharmaceutical separation and purification. They focus on the development and amplification of separation and purification process, selection and optimization of separation media, customization of separation and purification system, design and implementation of separation and purification projects, providing customer with total solution. In biological production process like filtration and separation, chromatography and purification, on-line buffer mixing, they can also provide automated, intelligent and personalized solution. Their products and services cover the whole biopharmaceutical process from medicine discovery, pilot scale-up to scale production. Now, Lisure provides more than 1000 biopharmaceutical enterprises and R&D institutions with products and services in monoclonal antibody, recombinant protein and bloods products.

Dr. Reddy's Laboratories Ltd. engages in the manufacture and marketing of pharmaceutical products. It operates through the following segments: Global Generics, Pharmaceutical Services & Active Ingredients, Proprietary Products, and Others. The Global Generics segment consists of manufacturing and marketing of prescription and over-the-counter finished pharmaceutical products ready for consumption by the patient, marketed under a brand name or as generic finished dosages with therapeutic equivalence to branded formulations. The Pharmaceutical Services & Active Ingredients segment is comprised of manufacturing and marketing of active pharmaceutical ingredients and intermediates, also known as API, which are the principal ingredients for finished pharmaceutical products. The Proprietary Products segment focuses on research and development of differentiated formulations. The Others segment includes the operations of the subsidiary of the company. The company was founded by Kallam Anji Reddy on February 24, 1984 and is headquartered in Hyderabad, India.

Shanghai WuXi Biotechnology Co., Ltd., established on 2015-01-06, Business scope includes licensed projects:pharmaceutical production;Drug import and export.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments) General project:Engaged in technology development in the field of biomedical technology,technical consulting,Technical Services,technology transfer;Engaged in the import and export of goods and technology,Re-export trade,Trade and trade agency between enterprises in the region,Class I medical device,Sales of Class II Medical Devices.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Alexion Pharmaceuticals is a biopharmaceutical company, which is engaged in the discovery, development, and commercialization of biologic therapeutic products aimed at treating patients with severe and life-threatening disease states, including hematologic, kidney and neurologic diseases, transplant rejection, cancer, and autoimmune disorders. Its marketed product Soliris (eculizumab) is a therapy approved for the treatment of patients with paroxysmal nocturnal hemoglobinuria (PNH). In April 2009 and August 2009, the United States food and drug administration (FDA) and the European Commission (E.C.), respectively, granted Soliris orphan drug designation for the treatment of patients with atypical Hemolytic Uremic Syndrome (aHUS). In December 2009, its Rhode Island manufacturing facility received regulatory approval from the E.C. Or the production of Soliris.

At EMD Millipore, one of the top three investors in R&D in the Life Science Tools industry

The Board of Trustees of the University of Illinois, part of University of Illinois, is a company headquartered in Urbana, IL, that trusts Except Educational Religious.

Anhui Jiuchuan Biotechnology Co., Ltd., established on 2011-02-23, Business scope includes research and development of biological products,Production,Sales;Research and development of biotechnology,transfer;production of cosmetics,Sales;laboratory consumables,laboratory apparatus,Production of disinfection equipment,Sales.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Nanjing Youai Biotechnology R&D Co., Ltd., established on 2018-09-10, Business scope includes biotechnology,medical diagnosis,Biological product,Reagents in medical technology,Research and development of consumables and equipment,Sales;Biological Technology,medical diagnosis,Biological product,Technical consulting in the field of medical science and technology,technology transfer,Technical Services;Sales of chemical products and raw materials;Software development and sales;Self-operated and agent import and export business of various commodities and technologies.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Shanghai Tianfeng Industrial Co., Ltd., established on 2006-01-11, The scope of business includes the production of laboratory equipment,craft jewelry(Does not contain gold and silver)the design of,processing;laboratory equipment,Technical consulting in the computer field,technology development,Technical Services,technology transfer;laboratory equipment,craft jewelry(Does not contain gold and silver),Communication equipment,Glasses,Sales of computer software, hardware and accessories. [Items subject to approval by law,Business activities can only be carried out after approval by relevant departments]

Wuhan Sanying Biotechnology Co., Ltd., established on 2003-01-27, Business scope includes biological products,Development of biochemical reagents,Production,Sales and related technical services.(In the above-mentioned scope of business, the projects with special provisions of the state shall be operated within the approved period after approval or with the license)